Violation Tracker Individual Record
Date:December 8, 2016
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Bristol-Myers Squibb agreed to pay $19.5 million to settle multistate litigation alleging that it illegally marketed the atypical antipsychotic drug Abilify.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:New York
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.